Ring Mountain Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$282K Buy
670
+24
+4% +$9.6K 0.12% 84
2026
Q2
$234K Buy
646
+2
+0.3% +$685 0.1% 101
2026
Q1
$227K Hold
644
– – 0.12% 89
2025
Q4
$213K Buy
+644
New +$204K 0.11% 93
2025
Q2
– Sell
-651
Closed -$203K – 98
2025
Q1
$203K Buy
+651
New +$192K 0.15% 88

Other funds holding AMGN

Ring Mountain Capital's AMGN Position: Q3 2026 in Review

Ring Mountain Capital increased its Amgen (AMGN) stake by 3.7% in Q3 2026, buying an estimated $9.6K and bringing the position to 670 shares worth $282K. The position accounts for 0.12% of the portfolio, ranked #84.

Ring Mountain Capital first reported a position in AMGN in Q1 2025 and has held it in 5 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Ring Mountain Capital held 670 shares of Amgen worth $282K as of Q3 2026.
  • Ring Mountain Capital bought 24 Amgen shares in Q3 2026, an estimated $9.6K.
  • Amgen made up 0.12% of Ring Mountain Capital's portfolio in Q3 2026, its #84 holding.
  • Ring Mountain Capital first reported a position in Amgen in Q1 2025 and has held it in 5 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Ring Mountain Capital's 13F filing for Q3 2026, filed 13 Oct 2026.